-
July 27, 2021 Psychedelic Companies HAVN Life Sciences, MINDCURE Health Reach Manufacturing MilestonesThe global supply chain of regulated psilocybin and ibogaine continues to grow as these Canadian...
-
July 27, 2021 Will MindMed Partner With Johnson & Johnson for 18MC? ( MNMD & J&J In the Speculation Zone)What's up Psychedelic Investors? We all know that MindMed (MNMD / MMED) has been talking...
-
July 26, 2021 Akome Biotech Patents Psychedelic Drug Formulation to Treat Parkinson’s DiseaseThere is currently no known cure for the disease affecting 10 million people worldwide, but...
-
July 25, 2021 Field Trip Uplists to Nasdaq | Cybin to NYSE | Mydecine MDMA Patent: Big Week For Psychedelic StocksBig Week For Psychedelic Stocks: Field Trip Uplists to Nasdaq, Cybin Uplists to NYSE &...
-
July 23, 2021 Psychedelic Business Spotlight: July 23, 2021This week in psychedelic business news: Psychedelics as a treatment for obesity and TBIs, plus...
-
July 22, 2021 Cybin Receives Conditional Approval to Trade on NYSE AmericanAnd in other psychedelic stock news, Origin Therapeutics launches to make equity investments in emerging...
-
July 22, 2021 PSYCHEDELICS & The Mental Health Crisis In America: Anxiety, Depression And Addiction ALL TIME HIGHSThe mental healthcare crisis is escalating: Are Psychedelic Medicines the Solution? Can psychedelics health North...
-
July 21, 2021 Wake Network Partners with Lieber Institute to Develop Genetics-Based Screening System for Psychedelic TherapiesFungi bioscience company describes the project as “one of the most robust genetics research initiatives...
-
July 19, 2021 Levitee Labs to Begin Trading on the CSE This WeekThe emerging wellness company aims to transform mental health and addiction treatments through the integration...
-
July 19, 2021 Third Psychedelic Stock ETF Coming Soon, Core One Labs Prepares to List on NASDAQAdvisorshares Plant Medicine ETF will be listed on the NYSE Arca under the symbol PSIL.
